Regulatory B cells, helminths, and multiple sclerosis

Area of Science:

• Immunology
• Neuroscience
• Parasitology

Background:

• Multiple sclerosis (MS) is an inflammatory central nervous system disease linked to autoimmunity and regulatory cell defects.
• Regulatory B cells, a functional subset of B cells, are known to promote immune tolerance and dampen inflammation.
• Previous research suggests helminth infections may influence MS disease activity.

Purpose of the Study:

• To investigate the role of regulatory B cells in helminth-infected multiple sclerosis patients.
• To determine if helminth infections modulate immune responses in MS.
• To explore the mechanisms by which regulatory B cells impact MS pathogenesis.

Main Methods:

• Selection of MS patients with and without helminth infection (including Trypanosoma cruzi).
• Isolation and stimulation of peripheral blood CD19(+) cells.
• Analysis of cell surface markers and cytokine secretion (IL-4, IL-6, IL-10, TNF-α, lymphotoxin, TGF-β).

Main Results:

• Helminth-infected MS patients exhibited significantly lower clinical and radiological disease activity.
• Parasite infection induced regulatory T cells and suppressive cytokines (IL-10, TGF-β).
• Regulatory B cell populations producing high levels of IL-10 were found exclusively in helminth-infected MS patients, mediated partly by the ICOS-B/RP-1 pathway.

Conclusions:

• Helminth infections can induce regulatory B cells that produce IL-10, suppressing immune responses in MS.
• This B cell-mediated suppression may contribute to the observed reduction in disease activity in infected MS patients.
• Regulatory B cells represent a potential therapeutic target for managing MS.